The Magic Remedies Act 1954 prohibits advertising that claims treatment, cure or prevention for 54 named diseases in India.
The Drugs and Magic Remedies (Objectionable Advertisement) Act 1954 prohibits advertising in India that claims treatment, cure or prevention for 54 named diseases. Despite its 1954 vintage, it is the most-invoked statute in modern healthcare-advertising takedowns and remains fully in force in 2026.
How it works.
- Cross-check every ad against the 54-disease list. Any claim of treatment, cure or prevention triggers a compliance review.
- Reframe outcome language as process language. "Cures diabetes" → "consultation for diabetes management under a qualified physician".
- Remove before/after imagery for listed conditions. B/A imagery is deemed a claim regardless of caption disclaimer.
- Store the reframe rationale. Audit trail for investigation response.
- Retrain creative teams quarterly. The list has expanded via notification twice since original enactment.
- Escalate borderline creatives to legal. Better a delayed launch than a takedown + fine.
Why it matters for
Indian healthcare.
The Magic Remedies Act is the most-active Indian healthcare-advertising statute despite being nearly 75 years old. Its language ("magic remedies") is antiquated but its list of 54 diseases and its blanket prohibition on treatment/cure/prevention claims for those conditions is enforced in 2026 with new vigour. Meta and Google both pre-screen against the Act. Consumer courts routinely order takedowns. Health-influencer accounts have received legal notices for reels making outcome claims for listed conditions. DCGI Drug Advertising Rules overlap with the Act; NMC social media guidelines add a doctor-conduct layer; ASCI codes add an advertising-standards layer. A clinic advertising in the listed-disease space must reframe every outcome claim as a process claim to stay compliant.
How ICG uses this.
ICG maintains a live copy of the 54-disease list and a reframing library that maps common outcome claims to compliant process-language equivalents. Every managed clinic creative in the listed-disease space is screened against this library before live deployment. Related: DCGI Drug Advertising, ASCI Medical Guidelines, ART Act 2021, Schedule J Drug List.
Frequently asked questions.
What are the 54 diseases?
Cancer, diabetes, obesity, sexual dysfunction, hair loss, greying of hair, height increase, deafness, epilepsy, fits, hysteria, insanity, leprosy, tuberculosis and 40 others — the full list is scheduled to the Act.
Does the Act cover clinics or only drug companies?
Both — any advertisement (defined broadly to include digital, social, WhatsApp broadcast) claiming treatment for a listed disease is prohibited, regardless of who is advertising.
Is IVF/infertility covered?
Yes — the Act lists sexual impotence and related conditions, and the ART Act 2021 tightened this further for fertility advertising. Fertility clinics have to phrase services around the process (consultation, workup) not the outcome (pregnancy guarantee).
What are the enforcement patterns in 2024-2026?
Consumer courts and state drug controllers have taken down thousands of Meta and Google ads under the Act. Platforms proactively enforce a pre-screening layer. Penalties include ad takedown, fines, and in some cases criminal complaint under Section 7 of the Act.
Audit your ads
against the 54-disease list.
ICG runs a free 30-min Brand & Growth Diagnostic that plugs into your live account and surfaces this metric against portfolio benchmarks.
